← Leaderboards
Pamela Taxel
University Of Connecticut Sch Of Med/Dnt
$261,998
Attributed
$261,998
Total exposure
21
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $41.5K · FY2005–08$50K$37.5K$25K$12.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$261,998 · 21
By mechanism
M01$189,498 · 20
R03$72,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Ernesto Canalis$18,979,065
- Marja Marie Hurley$9,299,761
- Julie A Wagner$4,732,937
- Sun-Kyeong Lee$2,742,005
- Lawrence Gideon Raisz$2,512,334
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHuman Therapy EvaluationMaleBone MetabolismHormone Regulation /Control MechanismSkeletal Disorder ChemotherapyHormone TherapyBone DensityHuman Old Age (65+)EstradiolOsteoporosisDrug Screening /EvaluationEstrogensMetabolism Disorder ChemotherapyAgingAromataseSex HormonesFundingCalcium MetabolismBone FractureHormone MetabolismInstitutionComputer Retrieval Of Information On Scientific Projects Database
Grant awards (39)
CLINICAL TRIAL: THE EFFECT OF RISEDRONATE ON BONE TURNOVER AND BONE MASS IN OLDE$7,368
M01 · FY2008 · RR · contact PI
ANASTROZOLE$4,094
M01 · FY2008 · RR · contact PI
EFFECTS OF ORAL ESTRADIOL THERAPY ON OSTEOCLASTOGENESIS$1,842
M01 · FY2008 · RR · contact PI
EFFECT OF LETROZOLE ON BONE MARKERS AND BLOOD PRESSURE$4,705
M01 · FY2007 · RR · contact PI
THE EFFECT OF RISEDRONATE ON BONE TURNOVER AND BONE MASS IN OLDER MEN RECEIVING$2,823
M01 · FY2007 · RR · contact PI
ACUTE ESTROGEN IN WOMEN$1,882
M01 · FY2007 · RR · contact PI
EFFECTS OF ORAL ESTRADIOL THERAPY ON OSTEOCLASTOGENESIS$1,412
M01 · FY2007 · RR · contact PI
THE EFFECT OF RISEDRONATE ON BONE TURNOVER AND BONE MASS IN OLDER MEN RECEIVING$17,922
M01 · FY2006 · RR · contact PI
ACUTE ESTROGEN IN WOMEN$5,782
M01 · FY2006 · RR · contact PI
EFFECT OF LETROZOLE ON BONE MARKERS AND BLOOD PRESSURE$4,047
M01 · FY2006 · RR · contact PI
ALENDRONATE$578
M01 · FY2006 · RR · contact PI
THE EFFECT OF RISEDRONATE ON BONE TURNOVER AND BONE MASS IN OLDER MEN RECEIVING$19,635
M01 · FY2005 · RR
EFFECTS OF ORAL ESTRADIOL THERAPY ON OSTEOCLASTOGENESIS$16,830
M01 · FY2005 · RR
EFFECT OF LETROZOLE ON BONE MARKERS AND BLOOD PRESSURE$2,805
M01 · FY2005 · RR
ALENDRONATE$2,181
M01 · FY2005 · RR
Acute Estrogen in Women$12,990
M01 · FY2004 · RR
Effect of Risedronate on Bone Turnover /Bone Mass in Men$9,552
M01 · FY2004 · RR
Alendronate$5,922
M01 · FY2004 · RR
Effects of Oral Estradiol Therapy on Osteoclastogenesis$5,731
M01 · FY2004 · RR
Men on Lupron for Prostate Cancer$4,776
M01 · FY2004 · RR
Effect of Oral Estrogen Therapy on Bone Turnover and Bon$955
M01 · FY2004 · RR
Estrogen regulation of osteoclastogenesis in older men$72,500
R03 · FY2003 · AG
EFFECT OF ESTROGEN ON BONE TURNOVER IN OLDER MEN WITH LOW BONE MASS$0
M01 · FY2002 · RR
EFFECT OF AROMATASE INHIBITION ON BONE TURNOVER IN OLDER MEN$0
M01 · FY2002 · RR
EFFECT OF ESTROGEN ON BONE TURNOVER IN OLDER MEN WITH LOW BONE MASS$4,361
M01 · FY2001 · RR
EFFECT OF AROMATASE INHIBITION ON BONE TURNOVER IN OLDER MEN$4,361
M01 · FY2001 · RR
EFFECT OF ESTROGEN ON BONE TURNOVER IN OLDER MEN WITH LOW BONE MASS$0
M01 · FY2001 · RR
EFFECT OF AROMATASE INHIBITION ON BONE TURNOVER IN OLDER MEN$0
M01 · FY2001 · RR
EFFECT OF AROMATASE INHIBITION ON BONE TURNOVER IN OLDER MEN$0
M01 · FY2001 · RR
EFFECT OF ESTROGEN ON BONE TURNOVER IN OLDER MEN WITH LOW BONE MASS$0
M01 · FY2001 · RR
EFFECT OF ESTROGEN ON BONE TURNOVER IN OLDER MEN WITH LOW BONE MASS$19,111
M01 · FY2000 · RR
EFFECT OF AROMATASE INHIBITION ON BONE TURNOVER IN OLDER MEN$19,111
M01 · FY2000 · RR
EFFECT OF ESTROGEN ON BONE TURNOVER IN OLDER MEN WITH LOW BONE MASS$4,361
M01 · FY2000 · RR
EFFECT OF ESTROGEN ON BONE TURNOVER IN OLDER MEN WITH LOW BONE MASS$4,361
M01 · FY2000 · RR
Estrogen therapy on bone turnover &mass in men with prostate cancer$0
M01 · FY2000 · RR
EFFECT OF AROMATASE INHIBITION ON BONE TURNOVER IN OLDER MEN$0
M01 · FY2000 · RR
Estrogen therapy on bone turnover &mass in men with prostate cancer$0
M01 · FY2000 · RR
EFFECT OF AROMATASE INHIBITION ON BONE TURNOVER IN OLDER MEN$0
M01 · FY2000 · RR
Estrogen therapy on bone turnover &mass in men with prostate cancer$0
M01 · FY2000 · RR